Jalalon, Wilma A.

HRN: 27-82-57  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/21/2025
09/28/2025
IV
500
Q8
Liver Cirrhosis
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: